Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1901 1
1903 1
1906 2
1907 2
1909 1
1923 2
1927 1
1930 2
1931 2
1932 1
1933 3
1935 1
1936 1
1939 1
1941 1
1943 2
1944 1
1945 7
1946 33
1947 40
1948 50
1949 51
1950 70
1951 92
1952 121
1953 95
1954 111
1955 133
1956 154
1957 165
1958 162
1959 146
1960 127
1961 180
1962 208
1963 243
1964 333
1965 237
1966 253
1967 320
1968 324
1969 324
1970 390
1971 399
1972 397
1973 356
1974 438
1975 418
1976 329
1977 401
1978 409
1979 413
1980 448
1981 436
1982 486
1983 501
1984 509
1985 572
1986 533
1987 512
1988 497
1989 588
1990 584
1991 566
1992 594
1993 582
1994 608
1995 732
1996 708
1997 708
1998 725
1999 749
2000 755
2001 834
2002 969
2003 1097
2004 1077
2005 1268
2006 1402
2007 1571
2008 1472
2009 1610
2010 1771
2011 1949
2012 2084
2013 2267
2014 2330
2015 2420
2016 2646
2017 2578
2018 2655
2019 2780
2020 3351
2021 3581
2022 3383
2023 3386
2024 1277

Text availability

Article attribute

Article type

Publication date

Search Results

64,282 results

Results by year

Filters applied: . Clear all
Page 1
Pathobiology and Diagnosis of Multiple Myeloma.
Brigle K, Rogers B. Brigle K, et al. Semin Oncol Nurs. 2017 Aug;33(3):225-236. doi: 10.1016/j.soncn.2017.05.012. Epub 2017 Jul 5. Semin Oncol Nurs. 2017. PMID: 28688533 Review.
OBJECTIVE: To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of multiple myeloma (MM). DATA SOURCES: Peer-reviewed articles and clinical guidelines. ...IMPLICATIONS FOR NURSING PRACTICE: Treat …
OBJECTIVE: To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of …
Roadmap to cure multiple myeloma.
Rodriguez-Otero P, Paiva B, San-Miguel JF. Rodriguez-Otero P, et al. Cancer Treat Rev. 2021 Nov;100:102284. doi: 10.1016/j.ctrv.2021.102284. Epub 2021 Aug 31. Cancer Treat Rev. 2021. PMID: 34597912 Free article. Review.
Despite significant advances in the treatment of multiple myeloma which had led to unprecedented rates of response and survival, patients still relapse, and cure remains elusive. We propose in this review a roadmap to achieve the dream of cure for multiple …
Despite significant advances in the treatment of multiple myeloma which had led to unprecedented rates of response and surviva …
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2022.
Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, Costello C, Devarakonda S, Elsedawy N, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Liedtke M, Martin T, Omel J, Sborov D, Shain K, Stockerl-Goldstein K, Weber D, Berardi RA, Kumar R, Kumar SK. Callander NS, et al. J Natl Compr Canc Netw. 2022 Jan;20(1):8-19. doi: 10.6004/jnccn.2022.0002. J Natl Compr Canc Netw. 2022. PMID: 34991075
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highli …
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supp …
Multiple myeloma: Every year a new standard?
Rajkumar SV. Rajkumar SV. Hematol Oncol. 2019 Jun;37 Suppl 1(Suppl 1):62-65. doi: 10.1002/hon.2586. Hematol Oncol. 2019. PMID: 31187526 Free PMC article. Review.
The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. ...
The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach …
Multiple myeloma.
Kyle RA, Rajkumar SV. Kyle RA, et al. Blood. 2008 Mar 15;111(6):2962-72. doi: 10.1182/blood-2007-10-078022. Blood. 2008. PMID: 18332230 Free PMC article. Review.
Multiple myeloma is a clonal plasma cell malignancy that accounts for slightly more than 10% of all hematologic cancers. ...The evolution of drug therapy and stem-cell transplantation for the treatment of myeloma, as well as the development of new agents, is …
Multiple myeloma is a clonal plasma cell malignancy that accounts for slightly more than 10% of all hematologic cancers. ...Th …
Multiple myeloma epidemiology and survival: A unique malignancy.
Kazandjian D. Kazandjian D. Semin Oncol. 2016 Dec;43(6):676-681. doi: 10.1053/j.seminoncol.2016.11.004. Epub 2016 Nov 10. Semin Oncol. 2016. PMID: 28061985 Free PMC article. Review.
Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of plasma cell dyscrasias, which begins with monoclonal gammopathy of unknown significance (MGUS) to overt plasma cell leukemia and extramed …
Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum …
Haematology: multiple myeloma.
Medical Masterclass contributors; Firth J. Medical Masterclass contributors, et al. Clin Med (Lond). 2019 Jan;19(1):58-60. doi: 10.7861/clinmedicine.19-1-58. Clin Med (Lond). 2019. PMID: 30651246 Free PMC article. Review. No abstract available.
Supportive Care in Multiple Myeloma.
Guzdar A, Costello C. Guzdar A, et al. Curr Hematol Malig Rep. 2020 Apr;15(2):56-61. doi: 10.1007/s11899-020-00570-9. Curr Hematol Malig Rep. 2020. PMID: 32172361 Review.
PURPOSE OF REVIEW: As novel therapies are expanding the life expectancy of patients with multiple myeloma, appropriate supportive care has become critical in the management of these patients. ...These results, along with updated guidelines from professional societie …
PURPOSE OF REVIEW: As novel therapies are expanding the life expectancy of patients with multiple myeloma, appropriate support …
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up().
Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U; EHA Guidelines Committee. Electronic address: guidelines@ehaweb.org; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Dimopoulos MA, et al. Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3. Ann Oncol. 2021. PMID: 33549387 Free article. No abstract available.
Smoldering multiple myeloma.
Rajkumar SV, Landgren O, Mateos MV. Rajkumar SV, et al. Blood. 2015 May 14;125(20):3069-75. doi: 10.1182/blood-2014-09-568899. Epub 2015 Apr 2. Blood. 2015. PMID: 25838344 Free PMC article. Review.
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM is distinguished from monoclonal gammopathy of undetermined significance by a much higher risk of progression to multiple myeloma (MM). There have been major advances …
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM is distinguished from monoclonal gammopa …
64,282 results
You have reached the last available page of results. Please see the User Guide for more information.